U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Substance Class Protein
Created
by admin
on Sat Dec 16 00:01:42 UTC 2023
Edited
by admin
on Sat Dec 16 00:01:42 UTC 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
7M19191IKG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TEDUGLUTIDE
DASH   INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
ALX 0600 (2-GLYCINE-1-33-GLUCAGON-LIKE PEPTIDE II (HUMAN))
Common Name English
TEDUGLUTIDE [USAN]
Common Name English
TEDUGLUTIDE [MI]
Common Name English
2-GLYCINE-1-33-GLUCAGON-LIKE PEPTIDE II (HUMAN)
Common Name English
ALX-0600
Code English
TEDUGLUTIDE [JAN]
Common Name English
TEDUGLUTIDE (RDNA ORIGIN)
Common Name English
ALX 0600
Code English
TEDUGLUTIDE RECOMBINANT [ORANGE BOOK]
Common Name English
Teduglutide [WHO-DD]
Common Name English
GATTEX
Brand Name English
TEDUGLUTIDE [MART.]
Common Name English
teduglutide [INN]
Common Name English
REVESTIVE
Brand Name English
TEDUGLUTIDE RECOMBINANT
ORANGE BOOK  
Common Name English
TEDUGLUTIDE [VANDF]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/01/077
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
WHO-ATC A16AX08
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
FDA ORPHAN DRUG 784820
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
NDF-RT N0000190992
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
EMA ASSESSMENT REPORTS REVESTIVE (AUTHORIZED: MALABSORPTION DISEASES)
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
FDA ORPHAN DRUG 126999
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
NCI_THESAURUS C548
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
WHO-VATC QA16AX08
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
Code System Code Type Description
DRUG CENTRAL
4718
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
MERCK INDEX
m10518
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY Merck Index
ChEMBL
CHEMBL2104987
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
DRUG BANK
DB08900
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
NCI_THESAURUS
C66582
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
NDF-RT
N0000175140
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY Glucagon-Like Peptide 2 [Chemical/Ingredient]
SMS_ID
100000124173
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
MESH
C494910
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
CHEBI
72305
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
RXCUI
1364468
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY RxNorm
DAILYMED
7M19191IKG
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
WIKIPEDIA
TEDUGLUTIDE
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
NDF-RT
N0000190990
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]
HSDB
8337
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
CAS
197922-42-2
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
NDF-RT
N0000175452
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY Analogs/Derivatives [Chemical/Ingredient]
FDA UNII
7M19191IKG
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
USAN
PP-09
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
EVMPD
SUB31909
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
INN
8444
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
IUPHAR
7049
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
EPA CompTox
DTXSID501027767
Created by admin on Sat Dec 16 00:01:42 UTC 2023 , Edited by admin on Sat Dec 16 00:01:42 UTC 2023
PRIMARY
Related Record Type Details
GLUCAGON-LIKE PEPTIDE 2 RECEPTOR
TARGET -> AGONIST
Related Record Type Details
Structure of (2S)-2-[(2-Methylpropan-2-yl)oxycarbonylamino]-4-oxo-4-phenylmethoxybutanoic acid
IMPURITY -> PARENT
Structure of N-[(1,1-Dimethylethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine
IMPURITY -> PARENT
Structure of (4S)-5-(tert-Butoxy)-4-([[(9H-fluoren-9-yl)methoxy]carbonyl]amino)-5-oxopentanoic acid
IMPURITY -> PARENT
Structure of Fmoc-O-tert-butyl-D-serine
IMPURITY -> PARENT
Structure of (2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]propanoic acid
IMPURITY -> PARENT
Structure of 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-oxo-4-(tritylamino)butanoic acid, (2S)-
IMPURITY -> PARENT
Structure of N2-Fmoc-N6-BOC-L-lysine
IMPURITY -> PARENT
Structure of 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-oxo-4-(tritylamino)butanoic acid, (2R)-
IMPURITY -> PARENT
Structure of N-(9-Fluorenylmethoxycarbonyl)-D-leucine
IMPURITY -> PARENT
Structure of Fmoc-O-tert-butyl-L-allothreonine
IMPURITY -> PARENT
Structure of L-Aspartic acid 4-tert-butyl ester
IMPURITY -> PARENT
Structure of Fmoc-D-Asp(tBu)-OH
IMPURITY -> PARENT
Related Record Type Details
TEDUGLUTIDE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
Biological Half-life PHARMACOKINETIC
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966